Elevated Liver Enzymes With Positive Hepatitis B Serology After Intravenous Immunoglobulin Treatment of Guillain-Barré Syndrome

被引：0

作者：

Patel, Shivam ^{[1
]}

Le, Kim Minh Ngoc ^{[2
]}

Puskoor, Sujith ^{[3
]}

Amaning, Judith ^{[2
]}

机构：

[1] Texas A&M Univ, Sch Med, Bryan, TX USA

[2] Baylor Scott & White Med Ctr Round Rock, Dept Gastroenterol, Round Rock, TX 78665 USA

[3] Baylor Scott & White Med Ctr Round Rock, Dept Internal Med, Round Rock, TX USA

来源：

ACG CASE REPORTS JOURNAL | 2023年 / 10卷 / 12期

关键词：

IVIG; Guillain-Barre syndrome; hepatitis B serology; liver enzyme elevation;

D O I：

10.14309/crj.0000000000001207

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Intravenous immunoglobulin (IVIG) is used to treat multiple conditions, one of which is Guillain-Barre syndrome. Despite its multiple benefits, IVIG can cause a wide variety of side effects, most of which resolve with supportive care. We present a case in which a patient with new-onset Guillain-Barre syndrome was treated with IVIG and subsequently developed an acute elevation in liver enzymes with positive hepatitis B serology.

引用

页数：3

共 50 条

[31] An unusual occurrence of opsoclonus and liver enzymes elevation in a patient with acute motor and sensory axonal neuropathy subtype of Guillain-Barré syndrome
Hasan Alzuhaily
Eman khashaneh
Sanaa Albkhetan
Fatima Abbas
BMC Neurology, 22
[32] Intravenous immunoglobulin treatment in a HIV-1 positive patient with Guillain-Barre syndrome
Rosca, Elena Cecilia
Rosca, Ovidiu
Simu, Mihaela
INTERNATIONAL IMMUNOPHARMACOLOGY, 2015, 29 (02) : 964 - 965
[33] Lack of efficacy after treatment with intravenous immunoglobulin in pediatric Guillain-Barre syndrome
Smith, AJ
Graf, WD
Eder, DN
Chun, MR
ANNALS OF NEUROLOGY, 1996, 40 (02) : 157 - 157
[34] Potential advantage of therapeutic plasma exchange over intravenous immunoglobulin in children with axonal variant of Guillain-Barré syndrome: A report of six paediatric cases
Deb, Joyisa
Negi, Gita
Mohan, Aswin K.
Sharawat, Indar Kumar
Banerjee, Pradip
Chauhan, Deepali
Kaur, Daljit
Jain, Ashish
TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2025, 32 (01) : 112 - 117
[35] Efficacy and safety of intravenous immunoglobulin retreatment amongst Guillain-Barré syndrome patients who poorly responded to initial IVIG cycle: a systematic review
Prado, Mario B.
Adiao, Karen Joy B.
Turalde, Christian Wilson R.
Dasig, Darwin A.
ACTA NEUROLOGICA BELGICA, 2024, 124 (04) : 1237 - 1250
[36] Comparison of intravenous immunoglobulin and plasma exchange in treatment of mechanically ventilated children with Guillain Barré syndrome: a randomized study
Mohammed A El-Bayoumi
Ahmed M El-Refaey
Alaa M Abdelkader
Mohamed MA El-Assmy
Angi A Alwakeel
Hanem M El-Tahan
Critical Care, 15
[37] A case of Guillain-Barré syndrome associated with cerebellar ataxia and positive serum anti-GD1b IgG antibody
Hideki Sugimoto
Nobuo Wakata
Masahiko Kishi
Toshiki Fujioka
Teruyuki Kurihara
Yukiko Irie
Toyokazu Saito
Journal of Neurology, 2002, 249 : 346 - 347
[38] Intravenous immunoglobulin exerts reciprocal regulation of Th1/Th17 cells and regulatory T cells in Guillain-Barr, syndrome patients
Maddur, Mohan S.
Rabin, Magalie
Hegde, Pushpa
Bolgert, Francis
Guy, Moneger
Vallat, Jean-Michel
Magy, Laurent
Bayry, Jagadeesh
Kaveri, Srini V.
IMMUNOLOGIC RESEARCH, 2014, 60 (2-3) : 320 - 329
[39] False-positive hepatitis B test results after intravenous immunoglobulin therapy
den Hoed-Krijnen, Anne Wil J.
Gregoor, Peter J. H. Smak
CLINICAL KIDNEY JOURNAL, 2019, 12 (03) : 463 - 463
[40] Prevalence and Clinical Profile of Headache after Intravenous Immunoglobulin Treatment in Patients with Guillain-Barre Syndrome
Ikeda, K.
Sawada, M.
Hanashiro, S.
Yanagihashi, M.
Ishikawa, Y.
Hirayama, T.
Takazawa, T.
Murata, K.
Kawabe, K.
Iwasaki, Y.
HEADACHE, 2014, 54 : 61 - 62

← 1 2 3 4 5 →